Total Payments
$2,792
2024 Payments
$466.67
Companies
15
Transactions
65
Medicare Patients
20,336
Medicare Billing
$9.2M
Payment Breakdown by Category
Food & Beverage$2,671 (95.7%)
Other$120.35 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,671 | 63 | 95.7% |
| Entertainment | $120.35 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alimera Sciences, Inc. | $537.48 | 15 | $0 (2024) |
| Genentech USA, Inc. | $448.19 | 16 | $0 (2023) |
| Heru, Inc. | $404.84 | 1 | $0 (2022) |
| Marco Ophthalmic, Inc. | $253.65 | 2 | $0 (2017) |
| Mallinckrodt Hospital Products Inc. | $224.69 | 14 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $189.58 | 2 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $174.35 | 1 | $0 (2024) |
| Optos, Inc. | $139.12 | 3 | $0 (2021) |
| Astellas Pharma US Inc | $133.61 | 1 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $111.10 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $466.67 | 4 | Bausch & Lomb Americas Inc. ($174.35) |
| 2023 | $99.18 | 1 | Genentech USA, Inc. ($99.18) |
| 2022 | $551.66 | 7 | Heru, Inc. ($404.84) |
| 2021 | $438.02 | 25 | Mallinckrodt Hospital Products Inc. ($198.73) |
| 2020 | $231.16 | 6 | Alimera Sciences, Inc. ($122.43) |
| 2019 | $305.94 | 7 | Bausch & Lomb, a division of Bausch Health US, LLC ($172.36) |
| 2018 | $202.75 | 8 | Genentech USA, Inc. ($140.43) |
| 2017 | $496.12 | 7 | Marco Ophthalmic, Inc. ($253.65) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $133.61 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $135.16 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/10/2024 | Bausch & Lomb Americas Inc. | Stellaris (Device) | Food and Beverage | In-kind items and services | $174.35 | General |
| Category: Ophthalmology | ||||||
| 02/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/22/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $99.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/23/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| 08/09/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $26.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/05/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2022 | Heru, Inc. | Heru HMD (Device) | Food and Beverage | Cash or cash equivalent | $404.84 | General |
| Category: Ophthalmic | ||||||
| 03/16/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/26/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/25/2022 | Carl Zeiss Meditec USA, Inc. | LUMERA 700 (Device) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Surgical Microscope | ||||||
| 12/20/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2021 | Genentech USA, Inc. | SUSVIMO (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/22/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/27/2021 | Genentech USA, Inc. | SUSVIMO (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/06/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/09/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $1.30 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 5,532 | 22,081 | $6.5M | $2.2M |
| 2022 | 22 | 5,714 | 18,202 | $6.7M | $2.4M |
| 2021 | 23 | 4,323 | 15,204 | $6.2M | $2.3M |
| 2020 | 20 | 4,767 | 14,554 | $6.8M | $2.3M |
Total Patients
20,336
Total Services
70,041
Medicare Billing
$9.2M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 168 | 4,124 | $2.1M | $764,549 | 37.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 1,122 | 2,016 | $591,408 | $207,848 | 35.1% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 93 | 849 | $455,300 | $182,012 | 40.0% |
| J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | Office | 2023 | 15 | 456 | $447,792 | $175,378 | 39.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 27 | 5,402 | $460,000 | $156,758 | 34.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 304 | 1,697 | $939,510 | $150,967 | 16.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 22 | 202 | $369,256 | $139,248 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,091 | 1,886 | $355,072 | $132,360 | 37.3% |
| 92134 | Imaging of retina | Office | 2023 | 678 | 2,046 | $174,270 | $61,625 | 35.4% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 141 | 254 | $141,221 | $53,307 | 37.7% |
| 92250 | Photography of the retina | Office | 2023 | 1,120 | 2,013 | $157,910 | $52,128 | 33.0% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 38 | 42 | $115,460 | $45,149 | 39.1% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 47 | 66 | $70,736 | $27,707 | 39.2% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 140 | 358 | $39,340 | $24,554 | 62.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 44 | 56 | $37,810 | $14,480 | 38.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 14 | $33,120 | $13,028 | 39.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 150 | 150 | $34,912 | $12,363 | 35.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 175 | 278 | $32,824 | $12,169 | 37.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 58 | 61 | $16,213 | $6,074 | 37.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 42 | 58 | $5,320 | $3,262 | 61.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 22 | 28 | $2,848 | $989.80 | 34.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 24 | 25 | $1,269 | $342.83 | 27.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 227 | 6,159 | $3.4M | $1.4M | 40.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 1,171 | 2,103 | $567,296 | $195,922 | 34.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 334 | 1,826 | $964,242 | $164,166 | 17.0% |
About Dr. Michael Samuel, M.D
Dr. Michael Samuel, M.D is a Ophthalmology healthcare provider based in Palm Desert, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730175670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Samuel, M.D has received a total of $2,792 in payments from pharmaceutical and medical device companies, with $466.67 received in 2024. These payments were reported across 65 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,671).
As a Medicare-enrolled provider, Samuel has provided services to 20,336 Medicare beneficiaries, totaling 70,041 services with total Medicare billing of $9.2M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Palm Desert, CA
- Active Since 09/26/2005
- Last Updated 04/05/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1730175670
Products in Payments
- Heru HMD (Device) $404.84
- ILUVIEN (Drug) $316.45
- Lucentis (Biological) $315.29
- OPD-III (Device) $253.65
- ACTHAR (Biological) $224.69
- Stellaris (Device) $174.35
- STELLARIS PC (Device) $172.36
- YUTIQ (Drug) $158.71
- Izervay (Drug) $133.61
- California (Device) $120.35
- Catalys Laser System (Device) $111.10
- Vabysmo (Drug) $99.18
- BEOVU (Drug) $60.99
- SUSVIMO (Drug) $33.72
- LUMERA 700 (Device) $29.83
- Spectralis (Device) $25.54
- PANORAMIC OPHTHALMOSCOPE (Device) $18.77
- STELLARIS (Device) $17.22
- Hylenex (Drug) $11.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Palm Desert
Clement Chan, M.d, M.D
Ophthalmology — Payments: $19,801
Ophthalmology $19,801
Dr. James Belville, Md, MD
Ophthalmology — Payments: $17,810
Ophthalmology $17,810
Joel Solano, M.d, M.D
Ophthalmology — Payments: $6,785
Ophthalmology $6,785
Dr. Alexander Chop, Ph.d. M.d, PH.D. M.D
Ophthalmology — Payments: $6,475
Ophthalmology $6,475
Forrest Murphy, Md, MD
Ophthalmology — Payments: $5,488
Ophthalmology $5,488
Steven Lin, M.d, M.D
Ophthalmology — Payments: $3,881
Ophthalmology $3,881